Literature DB >> 7518849

Coexpression of cytokeratin and vimentin intermediate filaments in benign and malignant sweat gland tumors.

F Eckert1, P A de Viragh, U Schmid.   

Abstract

The coexpression of cytokeratin and vimentin intermediate filaments has been immunohistochemically evaluated in 124 benign and malignant sweat gland tumors of various types in comparison to normal sweat glands. In addition, all neoplasms have been stained by an antibody to alpha-smooth muscle actin. Epithelial cells reacted with the pan-cytokeratin antibody lu-5. In normal sweat glands, vimentin immunoreactivity was restricted to myoepithelial cells and to some cells of the coiled duct. In benign sweat gland tumors (n = 88), coexpression of vimentin and alpha-smooth muscle actin was frequently found in basal cells of neoplasms considered to differentiate towards the secretory coil of the eccrine or apocrine gland. These included eccrine spiradenoma, apocrine cystadenoma, hidradenoma papilliferum, syringocystadenoma papilliferum, and cylindroma. Thus, in these tumors, vimentin-reactive cells corresponded to myoepithelial cells. Vimentin-positive cells were also found in 14 of 36 sweat gland carcinomas, including 1 case of sclerosing sweat duct carcinoma, 1 case of porocarcinoma, 4 cases of eccrine adenocarcinoma, 1 case of mucinous eccrine carcinoma, and 5 cases of apocrine adenocarcinoma. Co-expression of vimentin and alpha-smooth muscle actin was observed in some cells of eccrine and apocrine adenocarcinomas. Therefore, in these neoplasms, some vimentin-positive cells appear to represent myoepithelial cells. In contrast, vimentin-positive cells in all other malignant tumors did not express alpha-smooth muscle actin. Our results indicate that coexpression of cytokeratin and vimentin may be frequently found in a variety of benign and malignant sweat gland tumors. In the majority of these neoplasms, vimentin-positive cells correspond to myoepithelial cells. Because vimentin is not specific for myoepithelial cells, additional stains for alpha-smooth muscle actin should be performed to prove the myoepithelial nature of vimentin-positive cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518849     DOI: 10.1111/j.1600-0560.1994.tb00249.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

Review 1.  The application of immunohistochemistry in the diagnosis of bone tumors and tumor-like lesions.

Authors:  Zhenqiang Gao; Leonard B Kahn
Journal:  Skeletal Radiol       Date:  2005-09-28       Impact factor: 2.199

2.  Clinically malignant atypical glomus tumour.

Authors:  Fariba Binesh; Ali Akhavan; Shokouh Taghipour Zahir; Taghi Roshan Bovanlu
Journal:  BMJ Case Rep       Date:  2013-01-03

Review 3.  Circulating tumor cells in sarcomas: a brief review.

Authors:  Le Chang; Greg Asatrian; Sarah M Dry; Aaron W James
Journal:  Med Oncol       Date:  2014-12-10       Impact factor: 3.064

4.  Plasmacytoid cells in salivary-gland pleomorphic adenomas: evidence of luminal cell differentiation.

Authors:  Yuzo Ogawa; Mitsunobu Kishino; Yukako Atsumi; Masaya Kimoto; Yasuo Fukuda; Takeshi Ishida; Naokuni Ijuhin
Journal:  Virchows Arch       Date:  2003-08-28       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.